GT BIOPHARMA, INC. Common Stock, Value, Issued
GT BIOPHARMA, INC. (GTBP) had Common Stock, Value, Issued of $45.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:CommonStockValue · last filed 2026-08-14
- 2026-06-30: Common Stock, Value, Issued $45.00K.
- 2026-03-31: Common Stock, Value, Issued $35.00K.
- 2025-12-31: Common Stock, Value, Issued $26.00K.
- 2025-09-30: Common Stock, Value, Issued $6.00K.
| Period end | Common Stock, Value, Issued | Common Stock, Value, Issued as first filed |
|---|---|---|
| 2026-06-30 | $45.00K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $35.00K 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $26.00K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $6.00K 10-Q/A · filed 2026-03-06 | |
| 2025-06-30 | $3.00K 10-Q/A · filed 2026-03-06 | |
| 2025-03-31 | $3.00K 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $2.00K 10-Q/A · filed 2026-03-06 | |
| 2024-09-30 | $2.00K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $2.00K 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $1.00K 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $1.00K 10-K · filed 2025-02-21 | |
| 2023-09-30 | $42.00K 10-Q · filed 2023-11-01 | |
| 2023-06-30 | $41.00K 10-Q · filed 2023-08-07 | |
| 2023-03-31 | $37.00K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $33.00K 10-K · filed 2024-03-26 | |
| 2022-09-30 | $33.00K 10-Q · filed 2022-10-31 | |
| 2022-06-30 | $31.00K 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $32.00K 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $32.00K 10-K · filed 2023-03-30 | |
| 2021-09-30 | $30.00K 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $28.00K 10-Q/A · filed 2021-12-29 | |
| 2021-03-31 | $21.00K 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $5.00K 10-K · filed 2022-03-28 | $52.00K 10-K · filed 2021-04-16 |
| 2020-09-30 | $78.00K 10-K · filed 2021-04-16 | |
| 2020-06-30 | $75.00K 10-K · filed 2021-04-16 | |
| 2020-03-31 | $71.00K 10-Q · filed 2020-05-15 | |
| 2019-12-31 | $41.00K 10-K · filed 2021-04-16 | $70.00K 10-K · filed 2020-03-27 |
| 2019-09-30 | $67.00K 10-Q · filed 2019-11-14 | |
| 2019-06-30 | $53.00K 10-Q · filed 2019-08-14 | |
| 2019-03-31 | $51.00K 10-Q · filed 2019-05-15 | |
| 2018-12-31 | $51.00K 10-K · filed 2020-03-27 | |
| 2018-09-30 | $50.00K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $50.00K 10-Q · filed 2018-08-14 | |
| 2018-03-31 | $50.00K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $50.00K 10-K · filed 2019-03-29 | |
| 2017-09-30 | $50.00K 10-Q · filed 2017-11-14 | |
| 2017-06-30 | $0.00 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $123.00K 10-Q · filed 2017-04-28 | |
| 2016-12-31 | $0.00 10-K · filed 2018-03-01 | $31.00K 10-K · filed 2017-03-31 |
| 2016-09-30 | $28.00K 10-Q/A · filed 2018-02-28 | |
| 2016-06-30 | $26.00K 10-Q/A · filed 2018-02-28 | |
| 2016-03-31 | $22.00K 10-Q/A · filed 2018-02-28 | |
| 2015-12-31 | $2.00K 10-K/A · filed 2018-02-28 | |
| 2015-09-30 | $600.00K 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $600.00K 10-Q · filed 2015-08-14 | |
| 2015-03-31 | $596.00K 10-Q · filed 2015-05-14 | |
| 2014-12-31 | $2.00K 10-K/A · filed 2018-02-28 | $592.00K 10-K · filed 2015-03-31 |
| 2014-09-30 | $592.00K 10-Q · filed 2015-01-08 | |
| 2014-06-30 | $574.00K 10-Q · filed 2015-01-08 | |
| 2014-03-31 | $574.00K 10-Q · filed 2015-01-08 | |
| 2013-12-31 | $574.00K 10-K · filed 2015-03-31 | |
| 2013-09-30 | $573.00K 10-Q · filed 2014-12-17 | |
| 2013-06-30 | $573.00K 10-Q · filed 2014-12-12 | |
| 2013-03-31 | $573.00K 10-Q · filed 2014-12-10 | |
| 2012-12-31 | $501.00K 10-K · filed 2015-01-08 | |
| 2012-09-30 | $457.00K 10-Q · filed 2012-11-21 | |
| 2012-06-30 | $364.00K 10-Q/A · filed 2012-09-13 | |
| 2012-03-31 | $300.00K 10-Q · filed 2012-05-21 | |
| 2011-12-31 | $269.00K 10-K · filed 2014-11-18 | |
| 2011-09-30 | $239.00K 10-Q · filed 2011-11-21 | |
| 2011-06-30 | $209.00K 10-Q/A · filed 2011-09-12 | |
| 2010-12-31 | $149.00K 10-K · filed 2012-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| STANDARD BIOTOOLS INC. (LAB) | United States | $0.297B | 3.80 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |